IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Latest 144 SEC Filings
Report of proposed sale of securities
CYTOGEN CORP, 144, 1997-04-03
FAQ
|
Privacy
|
Terms Of Service
|
Contact
© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission
